These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 28543168)

  • 1. A New Tool to Tackle the Opioid Epidemic: Description, Utility, and Results from the Maine Diversion Alert Program.
    Piper BJ; Desrosiers CE; Fisher HC; McCall KL; Nichols SD
    Pharmacotherapy; 2017 Jul; 37(7):791-798. PubMed ID: 28543168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Descriptive, observational study of pharmaceutical and non-pharmaceutical arrests, use, and overdoses in Maine.
    Simpson KJ; Moran MT; Foster ML; Shah DT; Chung DY; Nichols SD; McCall KL; Piper BJ
    BMJ Open; 2019 Apr; 9(4):e027117. PubMed ID: 31036710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Illicit and prescription drug misuse as reported to the Maine Diversion Alert Program.
    Piper BJ; Suarez MJ; Piserchio JP; Shah DT; Simoyan OM; McCall KL; Desrosiers CE; Nichols SD
    Forensic Sci Int; 2018 Apr; 285():65-71. PubMed ID: 29453006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increasing heroin, cocaine, and buprenorphine arrests reported to the Maine Diversion Alert Program.
    Simpson KJ; Moran MT; McCall KL; Herbert J; Foster ML; Simoyan OM; Shah DT; Desrosiers C; Nichols SD; Piper BJ
    Forensic Sci Int; 2019 Oct; 303():109924. PubMed ID: 31450173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use and Misuse of Opioids in Maine: Results From Pharmacists, the Prescription Monitoring, and the Diversion Alert Programs.
    Piper BJ; Desrosiers CE; Lipovsky JW; Rodney MA; Baker RP; McCall KL; Nichols SD; Martin SL
    J Stud Alcohol Drugs; 2016 Jul; 77(4):556-65. PubMed ID: 27340958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Examination of multiple drug arrests reported to the Maine Diversion Alert Program.
    Siddiqui MZ; Piserchio JP; Patel M; Park J; Foster ML; Desrosiers CE; Herbert J; Nichols SD; McCall KL; Piper BJ
    Forensic Sci Med Pathol; 2022 Jun; 18(2):133-140. PubMed ID: 35094290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The development of a comprehensive risk-management program for prescription opioid analgesics: researched abuse, diversion and addiction-related surveillance (RADARS).
    Cicero TJ; Dart RC; Inciardi JA; Woody GE; Schnoll S; Muñoz A
    Pain Med; 2007 Mar; 8(2):157-70. PubMed ID: 17305687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescription Monitoring Program Trends Among Individuals Arrested in Maine for Trafficking Prescription Drugs in 2014.
    McCall K; Nichols SD; Holt C; Ochs L; Cattabriga G; Tu C
    Pharmacotherapy; 2016 Jun; 36(6):585-9. PubMed ID: 27087386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling Opioid Abuse: A Case Study of the Opioid Crisis in New England.
    Butler C; Stechlinski P
    Bull Math Biol; 2023 Apr; 85(6):45. PubMed ID: 37088864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The US Opioid Crisis: Current Federal and State Legal Issues.
    Soelberg CD; Brown RE; Du Vivier D; Meyer JE; Ramachandran BK
    Anesth Analg; 2017 Nov; 125(5):1675-1681. PubMed ID: 29049113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the trends in medical use and misuse of opioid analgesics from 2004 to 2011.
    Atluri S; Sudarshan G; Manchikanti L
    Pain Physician; 2014; 17(2):E119-28. PubMed ID: 24658483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Going beyond prescription pain relievers to understand the opioid epidemic: the role of illicit fentanyl, new psychoactive substances, and street heroin.
    Pergolizzi JV; LeQuang JA; Taylor R; Raffa RB;
    Postgrad Med; 2018 Jan; 130(1):1-8. PubMed ID: 29190175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abuse-Deterrent Formulations and the Prescription Opioid Abuse Epidemic in the United States: Lessons Learned From OxyContin.
    Cicero TJ; Ellis MS
    JAMA Psychiatry; 2015 May; 72(5):424-30. PubMed ID: 25760692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding an emerging treatment population: Protocol for and baseline characteristics of a prospective cohort of people receiving treatment for pharmaceutical opioid dependence.
    Nielsen S; Lintzeris N; Murnion B; Degenhardt L; Bruno R; Haber P; Johnson J; Hardy M; Ling S; Saddler C; Dunlop A; Demirkol A; Silsbury C; Phung N; Houseman J; Larance B
    Drug Alcohol Rev; 2018 Nov; 37(7):887-896. PubMed ID: 30280448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic opioids: a ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids.
    Manchikanti L; Singh A
    Pain Physician; 2008 Mar; 11(2 Suppl):S63-88. PubMed ID: 18443641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rates of opioid dispensing and overdose after introduction of abuse-deterrent extended-release oxycodone and withdrawal of propoxyphene.
    Larochelle MR; Zhang F; Ross-Degnan D; Wharam JF
    JAMA Intern Med; 2015 Jun; 175(6):978-87. PubMed ID: 25895077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using poison center exposure calls to predict prescription opioid abuse and misuse-related emergency department visits.
    Davis JM; Severtson SG; Bucher-Bartelson B; Dart RC
    Pharmacoepidemiol Drug Saf; 2014 Jan; 23(1):18-25. PubMed ID: 24130046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increases in self-reported fentanyl use among a population entering drug treatment: The need for systematic surveillance of illicitly manufactured opioids.
    Cicero TJ; Ellis MS; Kasper ZA
    Drug Alcohol Depend; 2017 Aug; 177():101-103. PubMed ID: 28582697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in the medical management of patients on opioid analgesics following a diagnosis of substance abuse.
    Paulozzi LJ; Zhou C; Jones CM; Xu L; Florence CS
    Pharmacoepidemiol Drug Saf; 2016 May; 25(5):545-52. PubMed ID: 26861165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.